Annual Information Update

Dechra Pharmaceuticals PLC
28 September 2006







Issued by Citigate Dewe Rogerson Limited, Birmingham
Date: Thursday 28th September 2006

                                                               Embargoed: 7.00am

                           Dechra Pharmaceuticals PLC
                         (the 'Company' or the 'Group')
                           Annual Information Update


The Report & Accounts for the year ended 30 June 2006 has been posted to
shareholders.

A copy of the Report and Accounts document has also been submitted to the UK
Listing Authority. Further copies are available on request from the Company
Secretary, Dechra Pharmaceuticals PLC, Dechra House, Jamage Industrial Estate,
Talke Pits, Stoke-on-Trent, ST7 1XW or from the Group web-site (www.dechra.com).

Under the new rules introduced on 1 July 2005 relating to Prospectus Directives
by the UKLA, companies are required to list all regulatory news announcements
issued by the Company in the twelve month period preceding the date that the
published Accounts are issued to shareholders.

Dechra Pharmaceuticals PLC would like to advise that the following Regulatory
News Announcements have been issued by the Company over the period from 1
October 2005 to 29 September 2006:

29 September 2006   Annual Information Update
26 September 2006   Block Listing six monthly return
25 September 2006   Director/PDMR Shareholding
22 September 2006   Report & Accounts for the year ended 30 June 2006
                    Published
21 September 2006   Holding(s) in Company
19 September 2006   Director/PDMR Shareholding
15 September 2006   Blocklisting Interim Review
15 September 2006   Blocklisting Interim Review
5 September 2006    Additional Listing
5 September 2006    Final Results for the year ended 30 June 2006
21 August 2006      Notice of Results
27 July 2006        Change of Adviser
10 July 2006        Pre-Close Period Update
5 July 2006         Director/PDMR Shareholding
26 June 2006        Holding(s) in Company
21 June 2006        Director/PDMR Shareholding
12 June 2006        Holding(s) in Company
2 June 2006         EGM Statement
18 May 2006         Notice of EGM
8 March 2006        Additional Listing
28 February 2006    Interim Results for the six months ended 31 December 2005
24 February 2006    Holding(s) in Company
21 February 2006    Holding(s) in Company
20 January 2006     Holding(s) in Company
9 January 2006      Trading Update
19 October 2005     AGM Statement
19 October 2005     Adoption of IFRS
10 October 2005     Holding(s) in Company

Further details on the information contained within the above RNS announcements
can be viewed on the London Stock Exchange website: www.londonstockexchange.com
under code: DPH.

Enquiries:
Steve Whitehouse
Company Secretary 
Dechra Pharmaceuticals PLC
Tel: [phone]




                      This information is provided by RNS
            The company news service from the London Stock Exchange